EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies

Simona Gurzu, Rita Szodorai, Ioan Jung, Laura Banias

Journal of Cancer Research and Clinical Oncology · 23.05.2024 · 150 (5)

DOI: 10.1007/s00432-024-05781-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 23.05.2024. Verfasst von Simona Gurzu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Pharmacy, Science and Technology, George Emil Palade University of Medicine, 38 Gheorghe Marinescu Street, 540139, Targu Mur…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Carcinoma, Hepatocellular, Liver Neoplasms, Bile Duct Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the most common primary liver cancers. Little is known about the combined hepatocellular-cholangiocarcinoma (cHCC-ICC) variant and the proper therapeutic strategies. Out of over 1200 available studies about cHCC-ICC, we selected the most representative ones that reflected updated information with application to individualized therapy. Based on literature data and own experience, we hypothesize that two molecular groups of cHCC-ICC can be identified. The proposed division might have a significant therapeutic role. Most cases develop, like HCC, on a background of cirrhosis and hepatitis and share characteristics with HCC; thus, they are named HCC-type cHCC-ICC and therapeutic strategies might be like those for HCC. This review also highlights a new carcinogenic perspective and identifies, based on literature data and the own experience, a second variant of cHCC-ICC called ICC-type cHCC-ICC. Contrary to HCC, these cases show a tendency for lymph node metastases and ICC components in the metastatic tissues. No guidelines have been established yet for such cases. Individualized therapy should be, however, oriented toward the immunoprofile of the primary tumor and metastatic cells, and different therapeutic strategies should be used in patients with HCC- versus ICC-type cHCC-ICC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaCarcinoma, HepatocellularLiver NeoplasmsBile Duct NeoplasmsHumans

Stichwörter der Autor:innen

CarcinosarcomaCholangiocarcinomaHepatocellular carcinomaLymph node metastasesPrimary liver cancerStem cells

Autor:innen und Institutionen

  • Department of Pathology, Pharmacy, Science and Technology, George Emil Palade University of Medicine, 38 Gheorghe Marinescu Street, 540139, Targu Mures, Romania. simonagurzu@yahoo.com.
  • Research Center of Oncopathology and Transdisciplinary Research (CCOMT), Targu Mures, Romania. simonagurzu@yahoo.com.
  • Romanian Academy of Medical Sciences, Bucharest, Romania. simonagurzu@yahoo.com.
  • Department of Pathology, Pharmacy, Science and Technology, George Emil Palade University of Medicine, 38 Gheorghe Marinescu Street, 540139, Targu Mures, Romania.
  • Romanian Academy of Medical Sciences, Bucharest, Romania.

Zitieren

APA

Gurzu, S., Szodorai, R., Jung, I., & Banias, L. (2024). Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies. Journal of Cancer Research and Clinical Oncology, 150(5). https://doi.org/10.1007/s00432-024-05781-8

Vancouver

Gurzu S, Szodorai R, Jung I, Banias L. Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies. Journal of Cancer Research and Clinical Oncology. 2024;150(5). doi:10.1007/s00432-024-05781-8

BibTeX
@article{Gurzu2024,
  author = {Gurzu, Simona and Szodorai, Rita and Jung, Ioan and Banias, Laura},
  title = {Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  volume = {150},
  number = {5},
  doi = {10.1007/s00432-024-05781-8}
}
Kostenlos starten →